Livongo Health said today it will integrate continuous glucose data from Abbott‘s (NYSE:ABT) FreeStyle Libre Pro system into its Livongo for Diabetes system, touting it as the first such system to integrate data from Abbott’s FreeStyle Libre Pro.
With the integration, users of the FreeStyle Libre Pro will be able to see a visual snapshot of their glucose data as well as patterns and trends from within the data. The system will also allow users to share their Ambulatory Glucose Profiles with personal physicians to improve treatment decisions.
“Incorporating glucose data from the FreeStyle Libre Pro will enhance the Livongo member experience by providing personalized insights to influence behavior. Teaming up with Abbott supports our efforts to leverage valuable data across the healthcare ecosystem, so that our members receive the right information, tools and support when they need it most,” Livongo chief medical officer Dr. Jennifer Schneider said in a press release.
“At Abbott, we are revolutionizing glucose monitoring with technology that provides insightful, actionable information that allows people to make more informed decisions about their health. By integrating our expertise with Livongo’s approach to chronic-condition management, we are further empowering people with diabetes to live healthier lives,” Abbott diabetes care senior VP Jared Watkin said in a prepared statement.
In April, Livongo Health said that it acquired weight-management and disease-prevention program developer Retrofit for an undisclosed amount.